Selected research
Market Analysis & Forecast
Global Primidone Market Analysis and Forecast 2026-2032
Market perspective
The global Primidone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Primidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Primidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Primidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Primidone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Primidone include Amneal Pharm, Anda Repository, Dr Reddys Laboratories, Hikma Intl Pharms, Impax Laboratories, Lannett, Mutual Pharmaceutical, Oxford Pharms and Valeant, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Primidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Primidone, also provides the sales of main regions and countries. Of the upcoming market potential for Primidone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Primidone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Primidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Primidone sales, projected growth trends, production technology, application and end-user industry.
Primidone Segment by Company
Amneal Pharm
Anda Repository
Dr Reddys Laboratories
Hikma Intl Pharms
Impax Laboratories
Lannett
Mutual Pharmaceutical
Oxford Pharms
Valeant
Valeant Pharmaceuticals International
Vintage Pharmaceuticals
Watson Labs
West Ward Pharmaceutical
Xcel Pharmaceuticals
Primidone Segment by Type
50mg
250mg
Primidone Segment by Application
Epilepsy
Psychiatric Disorders
Essential Tremor
Primidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Primidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Primidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Primidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Primidone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 250mg
Applications
- Epilepsy
- Psychiatric Disorders
- Essential Tremor
Companies covered
- Amneal Pharm
- Anda Repository
- Dr Reddys Laboratories
- Hikma Intl Pharms
- Impax Laboratories
- Lannett
- Mutual Pharmaceutical
- Oxford Pharms
- Valeant
- Valeant Pharmaceuticals International
- Vintage Pharmaceuticals
- Watson Labs
- West Ward Pharmaceutical
- Xcel Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Primidone Market by Type
- 1.2.1 Global Primidone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 50mg
- 1.2.3 250mg
- 1.3 Primidone Market by Application
- 1.3.1 Global Primidone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Epilepsy
- 1.3.3 Psychiatric Disorders
- 1.3.4 Essential Tremor
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Primidone Market Dynamics
- 2.1 Primidone Industry Trends
- 2.2 Primidone Industry Drivers
- 2.3 Primidone Industry Opportunities and Challenges
- 2.4 Primidone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Primidone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Primidone Revenue by Region
- 3.2.1 Global Primidone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Primidone Revenue by Region (2021-2026)
- 3.2.3 Global Primidone Revenue by Region (2027-2032)
- 3.2.4 Global Primidone Revenue Market Share by Region (2021-2032)
- 3.3 Global Primidone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Primidone Sales by Region
- 3.4.1 Global Primidone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Primidone Sales by Region (2021-2026)
- 3.4.3 Global Primidone Sales by Region (2027-2032)
- 3.4.4 Global Primidone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Primidone Revenue by Manufacturers
- 4.1.1 Global Primidone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Primidone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Primidone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Primidone Sales by Manufacturers
- 4.2.1 Global Primidone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Primidone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Primidone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Primidone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Primidone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Primidone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Primidone Manufacturers, Product Type & Application
- 4.7 Global Primidone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Primidone Market CR5 and HHI
- 4.8.2 2025 Primidone Tier 1, Tier 2, and Tier 3
5 Primidone Market by Type
- 5.1 Global Primidone Revenue by Type
- 5.1.1 Global Primidone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Primidone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Primidone Revenue Market Share by Type (2021-2032)
- 5.2 Global Primidone Sales by Type
- 5.2.1 Global Primidone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Primidone Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Primidone Sales Market Share by Type (2021-2032)
- 5.3 Global Primidone Price by Type
6 Primidone Market by Application
- 6.1 Global Primidone Revenue by Application
- 6.1.1 Global Primidone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Primidone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Primidone Revenue Market Share by Application (2021-2032)
- 6.2 Global Primidone Sales by Application
- 6.2.1 Global Primidone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Primidone Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Primidone Sales Market Share by Application (2021-2032)
- 6.3 Global Primidone Price by Application
7 Company Profiles
- 7.1 Amneal Pharm
- 7.1.1 Amneal Pharm Company Information
- 7.1.2 Amneal Pharm Business Overview
- 7.1.3 Amneal Pharm Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Amneal Pharm Primidone Product Portfolio
- 7.1.5 Amneal Pharm Recent Developments
- 7.2 Anda Repository
- 7.2.1 Anda Repository Company Information
- 7.2.2 Anda Repository Business Overview
- 7.2.3 Anda Repository Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Anda Repository Primidone Product Portfolio
- 7.2.5 Anda Repository Recent Developments
- 7.3 Dr Reddys Laboratories
- 7.3.1 Dr Reddys Laboratories Company Information
- 7.3.2 Dr Reddys Laboratories Business Overview
- 7.3.3 Dr Reddys Laboratories Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Dr Reddys Laboratories Primidone Product Portfolio
- 7.3.5 Dr Reddys Laboratories Recent Developments
- 7.4 Hikma Intl Pharms
- 7.4.1 Hikma Intl Pharms Company Information
- 7.4.2 Hikma Intl Pharms Business Overview
- 7.4.3 Hikma Intl Pharms Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Hikma Intl Pharms Primidone Product Portfolio
- 7.4.5 Hikma Intl Pharms Recent Developments
- 7.5 Impax Laboratories
- 7.5.1 Impax Laboratories Company Information
- 7.5.2 Impax Laboratories Business Overview
- 7.5.3 Impax Laboratories Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Impax Laboratories Primidone Product Portfolio
- 7.5.5 Impax Laboratories Recent Developments
- 7.6 Lannett
- 7.6.1 Lannett Company Information
- 7.6.2 Lannett Business Overview
- 7.6.3 Lannett Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Lannett Primidone Product Portfolio
- 7.6.5 Lannett Recent Developments
- 7.7 Mutual Pharmaceutical
- 7.7.1 Mutual Pharmaceutical Company Information
- 7.7.2 Mutual Pharmaceutical Business Overview
- 7.7.3 Mutual Pharmaceutical Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Mutual Pharmaceutical Primidone Product Portfolio
- 7.7.5 Mutual Pharmaceutical Recent Developments
- 7.8 Oxford Pharms
- 7.8.1 Oxford Pharms Company Information
- 7.8.2 Oxford Pharms Business Overview
- 7.8.3 Oxford Pharms Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Oxford Pharms Primidone Product Portfolio
- 7.8.5 Oxford Pharms Recent Developments
- 7.9 Valeant
- 7.9.1 Valeant Company Information
- 7.9.2 Valeant Business Overview
- 7.9.3 Valeant Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Valeant Primidone Product Portfolio
- 7.9.5 Valeant Recent Developments
- 7.10 Valeant Pharmaceuticals International
- 7.10.1 Valeant Pharmaceuticals International Company Information
- 7.10.2 Valeant Pharmaceuticals International Business Overview
- 7.10.3 Valeant Pharmaceuticals International Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Valeant Pharmaceuticals International Primidone Product Portfolio
- 7.10.5 Valeant Pharmaceuticals International Recent Developments
- 7.11 Vintage Pharmaceuticals
- 7.11.1 Vintage Pharmaceuticals Company Information
- 7.11.2 Vintage Pharmaceuticals Business Overview
- 7.11.3 Vintage Pharmaceuticals Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Vintage Pharmaceuticals Primidone Product Portfolio
- 7.11.5 Vintage Pharmaceuticals Recent Developments
- 7.12 Watson Labs
- 7.12.1 Watson Labs Company Information
- 7.12.2 Watson Labs Business Overview
- 7.12.3 Watson Labs Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Watson Labs Primidone Product Portfolio
- 7.12.5 Watson Labs Recent Developments
- 7.13 West Ward Pharmaceutical
- 7.13.1 West Ward Pharmaceutical Company Information
- 7.13.2 West Ward Pharmaceutical Business Overview
- 7.13.3 West Ward Pharmaceutical Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 West Ward Pharmaceutical Primidone Product Portfolio
- 7.13.5 West Ward Pharmaceutical Recent Developments
- 7.14 Xcel Pharmaceuticals
- 7.14.1 Xcel Pharmaceuticals Company Information
- 7.14.2 Xcel Pharmaceuticals Business Overview
- 7.14.3 Xcel Pharmaceuticals Primidone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Xcel Pharmaceuticals Primidone Product Portfolio
- 7.14.5 Xcel Pharmaceuticals Recent Developments
8 North America
- 8.1 North America Primidone Market Size by Type
- 8.1.1 North America Primidone Revenue by Type (2021-2032)
- 8.1.2 North America Primidone Sales by Type (2021-2032)
- 8.1.3 North America Primidone Price by Type (2021-2032)
- 8.2 North America Primidone Market Size by Application
- 8.2.1 North America Primidone Revenue by Application (2021-2032)
- 8.2.2 North America Primidone Sales by Application (2021-2032)
- 8.2.3 North America Primidone Price by Application (2021-2032)
- 8.3 North America Primidone Market Size by Country
- 8.3.1 North America Primidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Primidone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Primidone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Primidone Market Size by Type
- 9.1.1 Europe Primidone Revenue by Type (2021-2032)
- 9.1.2 Europe Primidone Sales by Type (2021-2032)
- 9.1.3 Europe Primidone Price by Type (2021-2032)
- 9.2 Europe Primidone Market Size by Application
- 9.2.1 Europe Primidone Revenue by Application (2021-2032)
- 9.2.2 Europe Primidone Sales by Application (2021-2032)
- 9.2.3 Europe Primidone Price by Application (2021-2032)
- 9.3 Europe Primidone Market Size by Country
- 9.3.1 Europe Primidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Primidone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Primidone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Primidone Market Size by Type
- 10.1.1 China Primidone Revenue by Type (2021-2032)
- 10.1.2 China Primidone Sales by Type (2021-2032)
- 10.1.3 China Primidone Price by Type (2021-2032)
- 10.2 China Primidone Market Size by Application
- 10.2.1 China Primidone Revenue by Application (2021-2032)
- 10.2.2 China Primidone Sales by Application (2021-2032)
- 10.2.3 China Primidone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Primidone Market Size by Type
- 11.1.1 Asia Primidone Revenue by Type (2021-2032)
- 11.1.2 Asia Primidone Sales by Type (2021-2032)
- 11.1.3 Asia Primidone Price by Type (2021-2032)
- 11.2 Asia Primidone Market Size by Application
- 11.2.1 Asia Primidone Revenue by Application (2021-2032)
- 11.2.2 Asia Primidone Sales by Application (2021-2032)
- 11.2.3 Asia Primidone Price by Application (2021-2032)
- 11.3 Asia Primidone Market Size by Country
- 11.3.1 Asia Primidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Primidone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Primidone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Primidone Market Size by Type
- 12.1.1 SAMEA Primidone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Primidone Sales by Type (2021-2032)
- 12.1.3 SAMEA Primidone Price by Type (2021-2032)
- 12.2 SAMEA Primidone Market Size by Application
- 12.2.1 SAMEA Primidone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Primidone Sales by Application (2021-2032)
- 12.2.3 SAMEA Primidone Price by Application (2021-2032)
- 12.3 SAMEA Primidone Market Size by Country
- 12.3.1 SAMEA Primidone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Primidone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Primidone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Primidone Value Chain Analysis
- 13.1.1 Primidone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Primidone Production Mode & Process
- 13.2 Primidone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Primidone Distributors
- 13.2.3 Primidone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst